143 related articles for article (PubMed ID: 24466252)
1. A new tumorsphere culture condition restores potentials of self-renewal and metastasis of primary neuroblastoma in a mouse neuroblastoma model.
Cao D; Kishida S; Huang P; Mu P; Tsubota S; Mizuno M; Kadomatsu K
PLoS One; 2014; 9(1):e86813. PubMed ID: 24466252
[TBL] [Abstract][Full Text] [Related]
2. Th-MYCN mice with caspase-8 deficiency develop advanced neuroblastoma with bone marrow metastasis.
Teitz T; Inoue M; Valentine MB; Zhu K; Rehg JE; Zhao W; Finkelstein D; Wang YD; Johnson MD; Calabrese C; Rubinstein M; Hakem R; Weiss WA; Lahti JM
Cancer Res; 2013 Jul; 73(13):4086-97. PubMed ID: 23536557
[TBL] [Abstract][Full Text] [Related]
3. Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells.
Pezzolo A; Parodi F; Marimpietri D; Raffaghello L; Cocco C; Pistorio A; Mosconi M; Gambini C; Cilli M; Deaglio S; Malavasi F; Pistoia V
Cell Res; 2011 Oct; 21(10):1470-86. PubMed ID: 21403679
[TBL] [Abstract][Full Text] [Related]
4. Nucleolar protein PES1 is a marker of neuroblastoma outcome and is associated with neuroblastoma differentiation.
Nakaguro M; Kiyonari S; Kishida S; Cao D; Murakami-Tonami Y; Ichikawa H; Takeuchi I; Nakamura S; Kadomatsu K
Cancer Sci; 2015 Mar; 106(3):237-43. PubMed ID: 25557119
[TBL] [Abstract][Full Text] [Related]
5. The cultivation and identification of tumor stem cells from neuroblastoma derived tumor spheres.
Liu QX; Tang JY; Cai JY; Yin MZ; Li BS
Chin J Cancer; 2010 Dec; 29(12):1012-7. PubMed ID: 21114922
[TBL] [Abstract][Full Text] [Related]
6. MYCN enhances P-gp/MDR1 gene expression in the human metastatic neuroblastoma IGR-N-91 model.
Blanc E; Goldschneider D; Ferrandis E; Barrois M; Le Roux G; Leonce S; Douc-Rasy S; Bénard J; Raguénez G
Am J Pathol; 2003 Jul; 163(1):321-31. PubMed ID: 12819037
[TBL] [Abstract][Full Text] [Related]
7. Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling.
Pandian V; Ramraj S; Khan FH; Azim T; Aravindan N
Stem Cell Res Ther; 2015 Feb; 6(1):2. PubMed ID: 25888913
[TBL] [Abstract][Full Text] [Related]
8. miRNA expression profiling of the murine TH-MYCN neuroblastoma model reveals similarities with human tumors and identifies novel candidate miRNAs.
Terrile M; Bryan K; Vaughan L; Hallsworth A; Webber H; Chesler L; Stallings RL
PLoS One; 2011; 6(12):e28356. PubMed ID: 22164278
[TBL] [Abstract][Full Text] [Related]
9. L1-CAM knock-down radiosensitizes neuroblastoma IMR-32 cells by simultaneously decreasing MycN, but increasing PTEN protein expression.
Rached J; Nasr Z; Abdallah J; Abou-Antoun T
Int J Oncol; 2016 Oct; 49(4):1722-30. PubMed ID: 27432152
[TBL] [Abstract][Full Text] [Related]
10. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
[TBL] [Abstract][Full Text] [Related]
11. "A novel in vivo model for the study of human breast cancer metastasis using primary breast tumor-initiating cells from patient biopsies".
Marsden CG; Wright MJ; Carrier L; Moroz K; Pochampally R; Rowan BG
BMC Cancer; 2012 Jan; 12():10. PubMed ID: 22233382
[TBL] [Abstract][Full Text] [Related]
12. Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma.
Song L; Ara T; Wu HW; Woo CW; Reynolds CP; Seeger RC; DeClerck YA; Thiele CJ; Sposto R; Metelitsa LS
J Clin Invest; 2007 Sep; 117(9):2702-12. PubMed ID: 17710228
[TBL] [Abstract][Full Text] [Related]
13. Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell.
Hansford LM; McKee AE; Zhang L; George RE; Gerstle JT; Thorner PS; Smith KM; Look AT; Yeger H; Miller FD; Irwin MS; Thiele CJ; Kaplan DR
Cancer Res; 2007 Dec; 67(23):11234-43. PubMed ID: 18056449
[TBL] [Abstract][Full Text] [Related]
14. MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma.
Fabian J; Opitz D; Althoff K; Lodrini M; Hero B; Volland R; Beckers A; de Preter K; Decock A; Patil N; Abba M; Kopp-Schneider A; Astrahantseff K; Wünschel J; Pfeil S; Ercu M; Künkele A; Hu J; Thole T; Schweizer L; Mechtersheimer G; Carter D; Cheung BB; Popanda O; von Deimling A; Koster J; Versteeg R; Schwab M; Marshall GM; Speleman F; Erb U; Zoeller M; Allgayer H; Simon T; Fischer M; Kulozik AE; Eggert A; Witt O; Schulte JH; Deubzer HE
Oncotarget; 2016 Oct; 7(41):66344-66359. PubMed ID: 27572323
[TBL] [Abstract][Full Text] [Related]
15. Calreticulin regulates MYCN expression to control neuronal differentiation and stemness of neuroblastoma.
Lee AC; Shih YY; Zhou F; Chao TC; Lee H; Liao YF; Hsu WM; Hong JH
J Mol Med (Berl); 2019 Mar; 97(3):325-339. PubMed ID: 30612140
[TBL] [Abstract][Full Text] [Related]
16. Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence.
Taschner-Mandl S; Schwarz M; Blaha J; Kauer M; Kromp F; Frank N; Rifatbegovic F; Weiss T; Ladenstein R; Hohenegger M; Ambros IM; Ambros PF
Oncotarget; 2016 Jan; 7(3):3571-86. PubMed ID: 26657295
[TBL] [Abstract][Full Text] [Related]
17. Molecular and functional analysis of anchorage independent, treatment-evasive neuroblastoma tumorspheres with enhanced malignant properties: A possible explanation for radio-therapy resistance.
Abou-Antoun TJ; Nazarian J; Ghanem A; Vukmanovic S; Sandler AD
PLoS One; 2018; 13(1):e0189711. PubMed ID: 29298329
[TBL] [Abstract][Full Text] [Related]
18. Adaptation of the Th-MYCN Mouse Model of Neuroblastoma for Evaluation of Disseminated Disease.
Rahavi SM; Aletaha M; Farrokhi A; Lorentzian A; Lange PF; Maxwell CA; Lim CJ; Reid GSD
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569447
[TBL] [Abstract][Full Text] [Related]
19. Proliferation and Survival of Embryonic Sympathetic Neuroblasts by MYCN and Activated ALK Signaling.
Kramer M; Ribeiro D; Arsenian-Henriksson M; Deller T; Rohrer H
J Neurosci; 2016 Oct; 36(40):10425-10439. PubMed ID: 27707976
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a neuroblastoma mouse model by subcutaneous xenograft transplantation and its use to study metastatic neuroblastoma.
Gao Q; Chen CF; Dong Q; Hou L; Chen X; Zhi YL; Li X; Lu HT; Zhang HY
Genet Mol Res; 2015 Dec; 14(4):16297-307. PubMed ID: 26662423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
